Beginning in July 2011, investigators have enrolled approximately 30 women with stage II-IIIC invasive breast cancer in a clinical trial. All patients undergo neoadjuvant chemotherapy with 12 cycles of a weekly taxane followed by four cycles of …
http://ifttt.com/images/no_image_card.png
0 comments:
Post a Comment